{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:47:22Z","timestamp":1788893242334,"version":"build-2803163510"},"reference-count":39,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Saitama Medical University Hospital"},{"name":"Novartis Pharma Research"},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007664","name":"Manpei Suzuki Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Unprovoked A\u2212\u03b2+ ketosis-prone type 2 diabetes (KPD) is characterized by the sudden onset of diabetic ketosis\/ketoacidosis (DK\/DKA) without precipitating factors, negative anti-islet autoantibodies (\u201cA\u2212\u201d), and preservation of \u03b2-cell function (\u201c\u03b2+\u201d) after recovery from DKA. Although this phenotype often appears with acute hyperglycemia and DK\/DKA just like acute-onset type 1 diabetes (AT1D), the involvement of anti-islet immune responses remains unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We sought to clarify the immunological role of insulin-associated molecules in unprovoked A\u2212\u03b2+ KPD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this cross-sectional study, blood samples from 75 participants (42 with AT1D and 33 with KPD) were evaluated for interferon (IFN)-\u03b3\u2013secreting peripheral blood mononuclear cells (PBMCs) reactive to 4 insulin B-chain amino acid 9-23\u2013related peptides (B:9-23rPep) using an enzyme-linked immunospot (ELISpot) assay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 36.4% (12\/33) of KPD participants showed positive IFN-\u03b3 ELISpot assay results; the positivity rate in KPD was similar to that in AT1D (38.1%; 16\/42) and statistically significantly higher than the previously reported rate in type 2 diabetes (8%; 2\/25; P\u2005&amp;lt;\u2005.0167). Moreover, B:9-23rPep-specific IFN-\u03b3\u2013producing PBMC frequency was negatively correlated with age and ad lib serum C-peptide levels in all KPD participants and positively correlated with glycated hemoglobin A1c level in KPD participants with positive IFN-\u03b3 ELISpot results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings suggest the involvement of B:9-23rPep\u2013specific IFN-\u03b3\u2013related immunoreactivity in the pathophysiology of some unprovoked A\u2212\u03b2+ KPD. Moreover, increased immunoreactivity may reflect transiently decreased \u03b2-cell function and increased disease activity at the onset of DK\/DKA, thereby playing a key role in DK\/DKA development in this KPD phenotype.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab912","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T22:57:43Z","timestamp":1639868263000},"page":"e2124-e2132","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Significance of Insulin Peptide\u2013specific Interferon-\u03b3\u2013related Immune Responses in Ketosis-prone Type 2 Diabetes"],"prefix":"10.1210","volume":"107","author":[{"given":"Atsushi","family":"Satomura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-6751","authenticated-orcid":false,"given":"Yoichi","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Haisa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunpei","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"12","key":"2022041907513235200_CIT0001","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2337\/dc06-9916","article-title":"Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association","volume":"29","author":"Kitabchi","year":"2006","journal-title":"Diabetes Care."},{"issue":"12","key":"2022041907513235200_CIT0002","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2337\/dc06-1870","article-title":"Ketosis-prone type 2 diabetes: time to revise the classification of diabetes","volume":"29","author":"Umpierrez","year":"2006","journal-title":"Diabetes Care."},{"issue":"1","key":"2022041907513235200_CIT0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/dc12-1696","article-title":"Ketosis-prone atypical diabetes: glucagon is there, too","volume":"36","author":"Lefebvre","year":"2013","journal-title":"Diabetes Care."},{"issue":"12","key":"2022041907513235200_CIT0004","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/dc06-0749","article-title":"Accuracy and predictive value of classification schemes for ketosis-prone diabetes","volume":"29","author":"Balasubramanyam","year":"2006","journal-title":"Diabetes Care."},{"issue":"4","key":"2022041907513235200_CIT0005","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc09-1687","article-title":"Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission","volume":"33","author":"Gosmanov","year":"2010","journal-title":"Diabetes Care."},{"issue":"3","key":"2022041907513235200_CIT0006","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/dc09-1369","article-title":"Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes","volume":"33","author":"Umpierrez","year":"2010","journal-title":"Diabetes Care."},{"issue":"1","key":"2022041907513235200_CIT0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/dc12-0798","article-title":"\u03b2- And \u03b1-cell dysfunctions in Africans with ketosis-prone atypical diabetes during near-normoglycemic remission","volume":"36","author":"Choukem","year":"2013","journal-title":"Diabetes Care."},{"issue":"3","key":"2022041907513235200_CIT0008","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/db12-0624","article-title":"Pathogenesis of A\u2013\u03b2\u200a+ ketosis-prone diabetes","volume":"62","author":"Patel","year":"2013","journal-title":"Diabetes."},{"issue":"21","key":"2022041907513235200_CIT0009","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med."},{"issue":"4","key":"2022041907513235200_CIT0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1297\/cpe.23.99","article-title":"Type 1 diabetes and autoimmunity","volume":"23","author":"Kawasaki","year":"2014","journal-title":"Clin Pediatr Endocrinol."},{"issue":"8","key":"2022041907513235200_CIT0011","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest."},{"issue":"8","key":"2022041907513235200_CIT0012","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/eji.1830240820","article-title":"Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice","volume":"24","author":"Wegmann","year":"1994","journal-title":"Eur J Immunol."},{"issue":"7039","key":"2022041907513235200_CIT0013","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature."},{"issue":"2","key":"2022041907513235200_CIT0014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI8525","article-title":"A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin","volume":"107","author":"Alleva","year":"2001","journal-title":"J Clin Invest."},{"key":"2022041907513235200_CIT0015","doi-asserted-by":"crossref","first-page":"108260","DOI":"10.1016\/j.clim.2019.108260","article-title":"Significance of peripheral mononuclear cells producing interferon-\u03b3 in response to insulin B:9-23-related peptides in subtypes of type 1 diabetes","volume":"208","author":"Oikawa","year":"2019","journal-title":"Clin Immunol."},{"issue":"2","key":"2022041907513235200_CIT0016","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jdi.13120","article-title":"Bodyweight threshold for sudden onset of ketosis might exist in ketosis-prone type 2 diabetes patients","volume":"11","author":"Satomura","year":"2020","journal-title":"J Diabetes Investig."},{"issue":"11","key":"2022041907513235200_CIT0017","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","article-title":"New criteria for \u2018obesity disease\u2019 in Japan","volume":"66","author":"Examination Committee of Criteria for \u201cObesity Disease\u201d in Japan; Japan Society for the Study of Obesity","year":"2002","journal-title":"Circ J."},{"issue":"5","key":"2022041907513235200_CIT0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-144-5-200603070-00011","article-title":"Narrative review: ketosis-prone type 2 diabetes mellitus","volume":"144","author":"Umpierrez","year":"2006","journal-title":"Ann Intern Med."},{"issue":"11","key":"2022041907513235200_CIT0019","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1210\/jc.2003-030180","article-title":"Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes","volume":"88","author":"Maldonado","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022041907513235200_CIT0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jdi.12119","article-title":"Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus","volume":"5","author":"Kawasaki","year":"2014","journal-title":"J Diabetes Investig."},{"issue":"5","key":"2022041907513235200_CIT0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig."},{"issue":"4","key":"2022041907513235200_CIT0022","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jdi.13370","article-title":"Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8","volume":"12","author":"Kawasaki","year":"2021","journal-title":"J Diabetes Investig."},{"issue":"3","key":"2022041907513235200_CIT0023","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/01.pdr.0000200803.72985.3c","article-title":"T cell epitope mapping study with insulin overlapping peptides using ELISPOT assay in Japanese children and adolescents with type 1 diabetes","volume":"59","author":"Higashide","year":"2006","journal-title":"Pediatr Res."},{"issue":"12","key":"2022041907513235200_CIT0024","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-009-1539-9","article-title":"Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset","volume":"52","author":"Kawabata","year":"2009","journal-title":"Diabetologia."},{"issue":"5","key":"2022041907513235200_CIT0025","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.4049\/jimmunol.176.5.3257","article-title":"HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes","volume":"176","author":"Takaki","year":"2006","journal-title":"J Immunol."},{"issue":"7","key":"2022041907513235200_CIT0026","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/diab.42.7.1086","article-title":"Association of HLA-A24 with complete beta-cell destruction in IDDM","volume":"42","author":"Nakanishi","year":"1993","journal-title":"Diabetes."},{"issue":"10","key":"2022041907513235200_CIT0027","first-page":"3721","article-title":"Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction","volume":"84","author":"Nakanishi","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022041907513235200_CIT0028","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/BF00400951","article-title":"A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group","volume":"37","author":"Fennessy","year":"1994","journal-title":"Diabetologia."},{"key":"2022041907513235200_CIT0029","article-title":"Supplementary data for \u201cClinical significance of insulin peptide\u2013specific interferon-\u03b3\u2013related immune responses in ketosis-prone type 2 diabetes.\u201d","author":"Satomura"},{"issue":"1","key":"2022041907513235200_CIT0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573399811666150416122903","article-title":"Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness","volume":"12","author":"Faerch","year":"2016","journal-title":"Curr Diabetes Rev."},{"issue":"12","key":"2022041907513235200_CIT0031","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.2337\/dc12-2328","article-title":"Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes","volume":"36","author":"Brooks-Worrell","year":"2013","journal-title":"Diabetes Care."},{"issue":"8","key":"2022041907513235200_CIT0032","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/db06-0552","article-title":"T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes","volume":"56","author":"Goel","year":"2007","journal-title":"Diabetes."},{"issue":"1","key":"2022041907513235200_CIT0033","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/dc10-0579","article-title":"Identification of autoantibody-negative autoimmune type 2 diabetic patients","volume":"34","author":"Brooks-Worrell","year":"2011","journal-title":"Diabetes Care."},{"key":"2022041907513235200_CIT0034","doi-asserted-by":"crossref","first-page":"640251","DOI":"10.3389\/fimmu.2021.640251","article-title":"Islet autoimmunity in adults with impaired glucose tolerance and recently diagnosed, treatment na\u00efve type 2 diabetes in the Restoring Insulin SEcretion (RISE) Study","volume":"12","author":"Brooks-Worrell","year":"2021","journal-title":"Front Immunol."},{"issue":"12","key":"2022041907513235200_CIT0035","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.2337\/dc14-0961","article-title":"Impact of islet autoimmunity on the progressive \u03b2-cell functional decline in type 2 diabetes","volume":"37","author":"Brooks-Worrell","year":"2014","journal-title":"Diabetes Care."},{"issue":"2","key":"2022041907513235200_CIT0036","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/bip.21318","article-title":"On the mechanism of SDS-induced protein denaturation","volume":"93","author":"Bhuyan","year":"2010","journal-title":"Biopolymers."},{"issue":"8","key":"2022041907513235200_CIT0037","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI25350","article-title":"Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity","volume":"115","author":"Suri","year":"2005","journal-title":"J Clin Invest."},{"key":"2022041907513235200_CIT0038","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.mvr.2021.104254","article-title":"Association of chemokines IP-10\/CXCL10 and I-TAC\/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity","volume":"139","author":"Moreno","year":"2021","journal-title":"Microvasc Res."},{"issue":"3","key":"2022041907513235200_CIT0039","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.24.3.510","article-title":"Elevated serum IP-10 levels observed in type 1 diabetes","volume":"24","author":"Shimada","year":"2001","journal-title":"Diabetes Care."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab912\/42107201\/dgab912.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/5\/e2124\/43386307\/dgab912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/5\/e2124\/43386307\/dgab912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:52:51Z","timestamp":1650354771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/5\/e2124\/6469690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,18]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,12,18]]},"published-print":{"date-parts":[[2022,4,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab912","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,12,18]]}}}